Large population-based studies have established genetic dysregulation contributes 46–71% to the expression of the disease, with CFH and ARMS2/HTRA1 being the two most notable risk loci among the 103 identified AMD-associated loci so far [9–11]. This evidence concerns the gene CFH and age-related macular degeneration.